Sign In
Buy BMY
$56.60
+1.88 (+3.44%)
At Close: Jun 04, 2026
Biotech Stocks Stand to Benefit as Biden Announces Support for Industry
04:49pm, Monday, 12'th Sep 2022
With the CHIPS Act and Inflation Reduction Act (IRA) safely behind him, President Joe Biden has set his sights on helping grow another sector. Today he signed an executive order for the launch of a ne
Wells Fargo's Mohit Bansal: Abbvie has better long-term opportunity than Bristol-Myers
04:38pm, Monday, 12'th Sep 2022
Mohit Bansal, Wells Fargo, joins 'Closing Bell' to discuss Bristol-Myers shares rising on the FDA approval of its latest drug.
Bristol Myers shows fundamental momentum, says Aptus Capital Advisors' David Wagner
04:09pm, Monday, 12'th Sep 2022
Aptus Capital Advisors' David Wagner joins 'Power Lunch' to share his 3-stock picks, highlighting big movers: Carvana, Bristol Myers, and Newmont Corp.
Bristol-Myers Squibb Co (BMY) Morgan Stanley Global Healthcare Conference Call Transcript
01:42pm, Monday, 12'th Sep 2022
Bristol-Myers Squibb Co (NYSE:BMY ) Morgan Stanley Global Healthcare Conference September 12, 2022 8:10 AM ET Company Participants Christopher Boerner - EVP & Chief Commercialization Officer Conferenc
Bristol Myers Squibb Is a Must-Own Stock Right Now. Here's Why.
10:45am, Monday, 12'th Sep 2022
This blue chip big pharma stock offers investors a recession-proof business, a rising top line, and a solid dividend.
Pharmaceutical Stock Jumps on FDA Approval
10:23am, Monday, 12'th Sep 2022
Bristol-Meyers Squibb Co (NYSE:BMY) is up 6.4% at $74.62 at last glance and earlier traded as high as $75.99, after the U.S. Food and Drug Administration (FDA) approved Sotyktu, the company's oral tr
Bristol-Myers Squibb stock moves higher after FDA approval for its psoriasis drug
10:17am, Monday, 12'th Sep 2022
Yahoo Finance Live anchors Brad Smith, Julie Hyman and Brad Smith discuss stock performance for Bristol-Myers Squibb amid FDA drug approval.
Buffett Still Loves Occidental, but Here's Monday's Mammoth Market Mover
09:48am, Monday, 12'th Sep 2022
Good news for a big healthcare company has its stock moving higher as Wall Street looks to sustain its momentum from last week.
Bristol-Myers Squibb (BMY) Stock Jumps 8% as FDA Approves Psoriasis Treatment
09:37am, Monday, 12'th Sep 2022
Bristol-Myers Squibb (NYSE: BMY ) stock rose 8% over the weekend after the Food and Drug Administration (FDA) approved Sotyktu, its oral treatment for moderate-to-severe psoriasis. For the year BMY st
Bristol Myers Squibb rallies after FDA approves Sotyktu for psoriasis
05:48am, Monday, 12'th Sep 2022
Bristol Myers Squibb BMY, +1.12% shares rose 7% in premarket trade after the company said the U.S. Food and Drug Administration approved Sotyktu, which the drugmaker said was the first innovation in o
7 Blue-Chip Stocks to Buy Before the Bull Market Returns
07:03pm, Sunday, 11'th Sep 2022
Figuring out which blue-chip stocks to buy before the bull market returns can be a challenge. So far, declines on Wall Street have pushed the major averages into bear market territory.
Bristol Myers Squibb: Still A Buy Despite Some Concerns
06:12am, Sunday, 11'th Sep 2022
Bristol Myers Squibb showed substantial strength in the last months compared to the market. In the last weeks, momentum began to weaken due to some mixed pipeline updates and upcoming concerns about t
Stronger Outlook For Bristol-Myers Squibb
05:18pm, Friday, 09'th Sep 2022
BMY is down 12% from the 12-month high in late June, but has returned 13.9% for the YTD. The company maintained solid earnings growth through COVID and beyond.
2 Top Stocks to Buy In September and Hold Forever
07:45am, Friday, 09'th Sep 2022
Do not be intimidated by market turbulence.
Bristol-Myers Tops List of Most Successful Company Buyouts
04:33pm, Thursday, 08'th Sep 2022
Bristol-Myers Squibb Co. ( BMY , Financial) should stand up and take a bow. Its acquisition of Medarex in 2009 has proved to be one of the most successful buyouts in recent memory, given the cancer dr
